A lower GI series is a procedure in which a doctor uses x-rays and a chalky liquid called bariumto view your large intestine. The barium will make your large intestine more visible on an x-ray. The two types of lower GI series are a single-contrast lower GI series, which uses only barium and a double-contrast or air-contrast lower GI series, which uses both barium and air for a clearer view of your large intestine.
Scope of the Report:This report studies the Lower GI Series market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lower GI Series market by product type and applications/end industries.
A lower GI series can help a doctor find the cause of bleeding from anus, changes in bowel activity, chronic diarrhea, pain in abdomen and unexplained weight loss.
The global Lower GI Series market is valued at xx million USD in 2020 and is expected to reach xx million USD by the end of 2026, growing at a CAGR of xx% between 2020 and 2026.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lower GI Series.
Europe also play important roles in global market, with market size of xx million USD in 2020 and will be xx million USD in 2026, with a CAGR of xx%.
Market Segment by Companies, this report covers Eisai
Cadila Pharmaceuticals
Purdue Pharma
Peacehealth
Novadaq
Astrazeneca
Ironwood Pharmaceuticals
Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers Double-Contrast
Single-Contrast
Market Segment by Applications, can be divided into Gastroenteritis
Colon Polyps
Tumor
Strictures Crohn's Disease
Ulcerative Colitis
Others
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.